Aurinia Pharmaceuticals (AUPH) Revenue & Revenue Breakdown
Aurinia Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$158.53M
Latest Revenue (Q)
$57.19M
Main Segment (Y)
Product
Main Geography (Y)
UNITED STATES
Aurinia Pharmaceuticals Revenue by Period
Aurinia Pharmaceuticals Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $158.53M | 18.28% |
2022-12-31 | $134.03M | 193.89% |
2021-12-31 | $45.60M | -9.00% |
2020-12-31 | $50.12M | 15660.38% |
2019-12-31 | $318.00K | -31.32% |
2018-12-31 | $463.00K | 10.24% |
2017-12-31 | $420.00K | 142.77% |
2016-12-31 | $173.00K | -26.38% |
2015-12-31 | $235.00K | -15.47% |
2014-12-31 | $278.00K | -70.69% |
2013-12-31 | $948.56K | -84.60% |
2012-12-31 | $6.16M | 563.90% |
2011-12-31 | $927.52K | -72.88% |
2010-12-31 | $3.42M | -15.59% |
2009-12-31 | $4.05M | 4.52% |
2008-12-31 | $3.88M | 66.05% |
2007-12-31 | $2.33M | -33.72% |
2006-12-31 | $3.52M | 199.06% |
2005-12-31 | $1.18M | -7.51% |
2004-12-31 | $1.27M | -83.38% |
2003-12-31 | $7.66M | -35.71% |
2002-12-31 | $11.92M | 124.97% |
2001-12-31 | $5.30M | 486.77% |
2000-11-30 | $902.77K | -33.53% |
1999-11-30 | $1.36M | 73.85% |
1998-11-30 | $781.25K | - |
Aurinia Pharmaceuticals Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $57.19M | 13.70% |
2024-03-31 | $50.30M | 11.55% |
2023-12-31 | $45.09M | -17.28% |
2023-09-30 | $54.52M | 31.38% |
2023-06-30 | $41.49M | 20.59% |
2023-03-31 | $34.41M | 21.01% |
2022-12-31 | $28.43M | -49.02% |
2022-09-30 | $55.78M | 97.86% |
2022-06-30 | $28.19M | 30.36% |
2022-03-31 | $21.63M | -7.60% |
2021-12-31 | $23.40M | 59.57% |
2021-09-30 | $14.67M | 121.56% |
2021-06-30 | $6.62M | 624.29% |
2021-03-31 | $914.00K | -98.17% |
2020-12-31 | $50.03M | 172417.24% |
2020-09-30 | $29.00K | - |
2020-06-30 | $29.00K | -3.33% |
2020-03-31 | $30.00K | 3.45% |
2019-12-31 | $29.00K | -87.39% |
2019-09-30 | $230.00K | 693.10% |
2019-06-30 | $29.00K | -3.33% |
2019-03-31 | $30.00K | 3.45% |
2018-12-31 | $29.00K | -92.27% |
2018-09-30 | $375.00K | 1193.10% |
2018-06-30 | $29.00K | -3.33% |
2018-03-31 | $30.00K | -3.23% |
2017-12-31 | $31.00K | 6.90% |
2017-09-30 | $29.00K | -91.19% |
2017-06-30 | $329.00K | 961.29% |
2017-03-31 | $31.00K | 3.33% |
2016-12-31 | $30.00K | -3.23% |
2016-09-30 | $31.00K | -43.64% |
2016-06-30 | $55.00K | -3.51% |
2016-03-31 | $57.00K | - |
2015-12-31 | $57.00K | - |
2015-09-30 | $57.00K | -3.39% |
2015-06-30 | $59.00K | -4.84% |
2015-03-31 | $62.00K | -8.82% |
2014-12-31 | $68.00K | -5.56% |
2014-09-30 | $72.00K | 1.41% |
2014-06-30 | $71.00K | 5.97% |
2014-03-31 | $67.00K | -90.33% |
2013-12-31 | $692.64K | 721.28% |
2013-09-30 | $84.34K | 2.00% |
2013-06-30 | $82.69K | -5.47% |
2013-03-31 | $87.47K | 1.47% |
2012-12-31 | $86.21K | -1.34% |
2012-09-30 | $87.38K | -1.26% |
2012-06-30 | $88.49K | -98.48% |
2012-03-31 | $5.81M | 4745.76% |
2011-12-31 | $119.97K | -77.57% |
2011-09-30 | $534.84K | 250.00% |
2011-06-30 | $152.81K | 10.83% |
2011-03-31 | $137.87K | -53.70% |
2010-12-31 | $297.75K | 12.95% |
2010-09-30 | $263.62K | -81.35% |
2010-06-30 | $1.41M | -2.37% |
2010-03-31 | $1.45M | -12.58% |
2009-12-31 | $1.66M | 72.55% |
2009-09-30 | $959.87K | 55.20% |
2009-06-30 | $618.46K | -4.42% |
2009-03-31 | $647.03K | 592.40% |
2008-12-31 | $93.45K | -96.54% |
2008-09-30 | $2.70M | 386.86% |
2008-06-30 | $555.12K | -1.32% |
2008-03-31 | $562.52K | -8.72% |
2007-12-31 | $616.27K | - |
Aurinia Pharmaceuticals Revenue Breakdown
Aurinia Pharmaceuticals Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
---|---|---|---|---|
Product | $158.53M | $103.47M | $45.49M | - |
License, Collaboration and Royalty Revenue | $16.98M | - | - | - |
License | - | $30.56M | $117.00K | $50.12M |
Latest
Quarterly Revenue by Product
Product/Service | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Product | $55.50M | $55.03M | $48.07M | $42.31M | $40.78M | $41.10M | $34.34M | $28.33M | $25.50M | $28.15M | $21.49M | $23.38M | $14.64M | $6.59M | $30.00K |
License, Royalty and Collaboration Revenue | $12.27M | $2.16M | $2.23M | $13.73M | $394.00K | $72.00K | - | - | - | - | - | - | - | - | - |
License | - | - | - | - | - | - | - | $109.00K | $30.28M | $43.00K | $133.00K | $29.00K | $29.00K | $29.00K | $884.00K |
Latest
Aurinia Pharmaceuticals Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
UNITED STATES | $157.96M | $102.46M | $45.49M | - | $200.00K |
JAPAN | $17.55M | $31.48M | - | $50.00M | - |
Other Country | - | $89.00K | $117.00K | - | - |
CHINA | - | - | - | $118.00K | $118.00K |
Latest
Aurinia Pharmaceuticals Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
EXEL | Exelixis | $1.83B | $478.06M |
SRPT | Sarepta Therapeutics | $1.24B | $362.93M |
PTCT | PTC Therapeutics | $937.82M | $135.42M |
AXSM | Axsome Therapeutics | $270.60M | $87.17M |
TGTX | TG Therapeutics | $233.66M | $83.88M |
AUPH | Aurinia Pharmaceuticals | $158.53M | $57.19M |
MCRB | Seres Therapeutics | $126.33M | - |
BTAI | BioXcel Therapeutics | $1.38M | $1.10M |
VKTX | Viking Therapeutics | - | - |
MDGL | Madrigal Pharmaceuticals | - | $62.17M |
TERN | Terns Pharmaceuticals | - | - |
AKRO | Akero Therapeutics | - | - |
HEPA | Hepion Pharmaceuticals | - | - |